Coinbase Chooses Abu Dhabi as Its Global Hub for Tokenized Securities

cryptonews.ruPublished on 2026-08-20Last updated on 2026-08-20

Abstract

Coinbase has selected Abu Dhabi as its global hub for tokenized securities, receiving regulatory approval from the Abu Dhabi Global Market Financial Services Regulatory Authority. This license allows Coinbase to operate investment and custodial services for its tokenized securities business. The company described this move as a critical step toward building infrastructure for a more open and accessible global financial system. Under the new license, all securities issued by Coinbase will be backed by underlying shares and supervised by the Abu Dhabi regulator. Holders of these tokenized assets can store them in digital wallets without needing traditional brokerage accounts, though Coinbase will screen all transactions for sanctions compliance and may block them if necessary. Coinbase is entering an Abu Dhabi market where other firms, like Ondo Finance, have also received approval for blockchain-based investment products. The exchange has already launched tokenized stocks elsewhere, including SpaceX, Nvidia, and Google, backed 1:1 by the underlying assets.

According to Coinbase, the Financial Services Regulatory Authority of Abu Dhabi Global Market has granted the company permission to arrange investment deals and provide custodial services for its new tokenized securities business.

This is the most important step towards creating the infrastructure for a more open and accessible global financial system, Coinbase stated.

Thanks to the new license, all securities issued by Coinbase will be backed by underlying shares and supervised by the Abu Dhabi regulator. At the same time, holders of tokenized assets will be able to store them in their digital wallets without opening a traditional brokerage account. However, Coinbase will verify all transfers for compliance with sanctions, and they may be blocked if necessary.

The American crypto exchange is entering the Abu Dhabi market, where other companies have already received permission to work with blockchain-based investment products. For example, in March, Ondo Finance received approval to tokenize U.S. stocks and exchange-traded funds within the ADGM framework. Coinbase has already begun offering tokenized securities in other countries: in June, the exchange launched tokenized shares of SpaceX, Nvidia, Google, Strategy, and Bitmine, which are backed on a 1:1 basis.

end-content

Related Questions

QWhich regulatory body in Abu Dhabi granted Coinbase the license to operate its tokenized securities business?

AThe Abu Dhabi Global Market's Financial Services Regulatory Authority granted Coinbase the license.

QWhat are the two main services that Coinbase's new license in Abu Dhabi allows it to perform for tokenized securities?

AThe license allows Coinbase to operate an investment exchange and provide custodial services for its new tokenized securities business.

QWhat is a key benefit for users holding tokenized assets according to the article?

AHolders can store the tokenized assets in their own digital wallets without needing to open a traditional brokerage account.

QWhich other company in Abu Dhabi has also received permission to tokenize U.S. stocks and ETFs, as mentioned in the article?

AOndo Finance received permission to tokenize U.S. stocks and exchange-traded funds (ETFs) within the Abu Dhabi Global Market.

QWhat examples of tokenized stocks did Coinbase already launch in other countries in June?

AIn June, Coinbase launched tokenized securities for SpaceX, Nvidia, Google, Strategy, and Bitmine.

Related Reads

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbit30m ago

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbit30m ago

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbit30m ago

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbit30m ago

Trading

Spot
活动图片